| Literature DB >> 29728881 |
Komal Rizwan1,2, Muhammad Zubair3, Nasir Rasool4, Tariq Mahmood5, Khurshid Ayub5, Noorjahan Banu Alitheen6, Muhammad Nazirul Mubin Aziz7, Muhammad Nadeem Akhtar8, Faiz-Ul-Hassan Nasim9, Snober Mona Bukhary9, Viqar Uddin Ahmad10, Mubeen Rani10.
Abstract
Thiophene derivatives have shown versatile pharmacological activities. The Suzuki reaction proved a convenient method for C-C bond formations in organic molecules. In the present research work novel derivatives ofEntities:
Keywords: Antibacterial; Antioxidant; Density functional theory; Palladium; Thiophene
Year: 2018 PMID: 29728881 PMCID: PMC5935605 DOI: 10.1186/s13065-018-0404-7
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Scheme 1Synthesis of 2-bromo-3-methyl-5-arylthiophenes (3a–k) and 2,5-diaryl-3-methyl thiophenes (3l–p). Conditions: (i) 1 (128 mg, 0.5 mmol, 1 eq), 2 (0.55 mmol, 1.1 eq), Pd(PPh3)4 (14.5 mg, 2.5 mol%), K3PO4 (212 mg, 1.0 mmol, 2 eq), 1,4-dioxane (2.5 ml), H2O (0.625 ml), 12 h, 90 °C under argon. (ii) 1 (128 mg, 0.5 mmol, 1 eq), 2 (1.25 mmol, 2.5 eq,), Pd(PPh3)4 (34.6 mg, 6 mol%), K3PO4 (424 mg, 2.0 mmol, 4 eq), 1,4-dioxane (2.5 ml), H2O (0.625 ml), 12 h, 90 °C under argon
Substrate scope of Suzuki cross coupling reaction of 2,5-dibromo-3-methyl thiophene with variety of arylboronic acids
Fig. 1HOMO/LUMO surfaces of compounds (3a)
HOMO and LUMO energies, along with band gap
| Compounds no | EHOMO (eV) | ELUMO (eV) | ΔE (eV) |
|---|---|---|---|
|
| − 5.93 | − 1.39 | 4.54 |
|
| − 5.39 | − 0.92 | 4.47 |
|
| − 5.83 | − 1.38 | 4.45 |
|
| − 5.99 | − 1.50 | 4.49 |
|
| − 5.84 | − 1.69 | 4.15 |
|
| − 5.39 | − 1.12 | 4.26 |
|
| − 6.08 | − 1.77 | 4.31 |
|
| − 5.60 | − 1.06 | 4.52 |
|
| − 5.60 | − 1.05 | 4.55 |
|
| − 6.04 | − 1.43 | 4.61 |
|
| − 5.91 | − 1.40 | 4.50 |
|
| − 5.81 | − 1.59 | 4.21 |
|
| − 4.98 | − 0.86 | 4.12 |
|
| − 5.06 | − 1.16 | 3.89 |
|
| − 5.24 | − 1.04 | 4.19 |
|
| 6.05 | − 1.38 | 4.67 |
Fig. 2ESP maps of compounds 3a–3p, calculated at DFT/B3LYP/6-31G(d,p) level
Antioxidant potential of compounds (3a–k and 3l–p) by DPPH radical scavenging activity
| Entry | Compounds no | Percentage inhibition at 50 µg/ml |
|---|---|---|
| 1 |
| 33.4 ± 0.29 |
| 2 |
| 23.9 ± 0.31 |
| 3 |
| 37.5 ± 0.42 |
| 4 |
| 48.2 ± 0.42 |
| 5 |
| 38.5 ± 0.42 |
| 6 |
| 39.2 ± 0.42 |
| 7 |
| 82.0 ± 0.78 |
| 8 |
| *** |
| 9 |
| 28.9 ± 0.45 |
| 10 |
| 81.3 ± 0.72 |
| 11 |
| 21.9 ± 0.32 |
| 12 |
| 86.0 ± 0.73 |
| 13 |
| 1.19 ± 0.02 |
| 14 |
| 40.9 ± 0.21 |
| 15 |
| 15.1 ± 0.21 |
| 16 |
| 30.9 ± 0.29 |
| 17 | Ascorbic acid | 100 ± 0.99 |
*** Showed no activity. The results are average ± SD of triplicate experiments p < 0.05
Antibacterial activity of synthesized compounds (3a–k and 3l–p) against Gram positive and Gram negative bacteria
| Entry | Product no | % inhibition (50 μg/ml) | ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| 1 |
| 67.3 ± 0.76 | *** | 94.5 ± 0.09 | 33.9 ± 0.37 | 27.6 ± 0.08 |
| 2 |
| 39.2 ± 0.45 | *** | 50.1 ± 0.29 | 9.57 ± 0.15 | 5.58 ± 0.05 |
| 3 |
| *** | *** | *** | *** | *** |
| 4 |
| 34.9 ± 0.27 | *** | 7.8 ± 0.09 | *** | 8.34 ± 0.23 |
| 5 |
| *** | *** | *** | *** | ** |
| 6 |
| *** | *** | *** | *** | *** |
| 7 |
| *** | *** | *** | *** | *** |
| 8 |
| 37.6 ± 0.26 | *** | 50.4 ± 0.45 | *** | 12.0 ± 0.02 |
| 9 |
| 41.1 ± 0.47 | *** | 70.4 ± 0.78 | *** | 2.59 ± 0.01 |
| 10 |
| *** | *** | *** | *** | *** |
| 11 |
| 50.5 ± 0.58 | *** | 72.5 ± 0.87 | 20.1 ± 0.06 | 17.3 ± 0.05 |
| 12 | *** | *** | *** | *** | *** | |
| 13 |
| *** | *** | *** | *** | *** |
| 14 |
| 20.8 ± 0.17 | *** | 30.6 ± 0.26 | *** | * |
| 15 |
| *** | *** | *** | *** | *** |
| 16 |
| *** | *** | *** | *** | *** |
| 17 | Control | 100 ± 1.28 | 100 ± 1.21 | 100 ± 1.01 | 100 ± 0.99 | 100 ± 0.99 |
*** Showed no activity. The results are average ± SD of triplicate experiments p < 0.05. Streptomycin was used as control standard drug
Antiurease activity of synthesized compounds (3a–k and 3l–p)
| Entry | Compound no | Percentage inhibition at 50 µg/ml |
|---|---|---|
| 1 |
| 58.8 ± 0.58 |
| 2 |
| 67.7 ± 0.77 |
| 3 |
| 48.9 ± 0.65 |
| 4 |
| 54.7 ± 0.67 |
| 5 |
| 42.9 ± 0.45 |
| 6 |
| 40.3 ± 0.40 |
| 7 |
| 34.2 ± 0.38 |
| 8 |
| 38.8 ± 0.45 |
| 9 |
| 36.9 ± 0.45 |
| 10 |
| 52.1 ± 0.78 |
| 11 |
| 64.2 ± 0.87 |
| 12 | Thiourea | 95.6 ± 0.87 |
The results are average ± SD of triplicate experiments p < 0.05. Thiourea used as positive control